Alessandra Chiarot

Ms. Alessandra Chiarot


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
EMEveline S Menezes
Eveline S Menezes
HIHashim Islam
Hashim Islam
BABenjamin B Arhen
Benjamin B Arhen
ZWZeyu Wu
Zeyu Wu
LPLauren J Pacitti
Lauren J Pacitti
BGBrendon J Gurd
Brendon J Gurd
PERM1 has been identified as a key regulator of muscle energy metabolism, contractile function, and mitochondrial biogenesis. To investigate the impact fasting and acute and chronic high-intensity exercise on p38MAPK, pCaMKII, PGC-1α, ERRα, and PERM1 and on PERM1 target genes ( CKMT2, GLUT4, and SIRT3) in human skeletal muscle. We performed secondary analyses of muscle biopsy samples from two previously published studies, and from one unpublished study. Muscle biopsies were analyzed from the following protocols: (1) nine men pre-, during, and post- an 8 h fast with or without 2 h of arm ergometer exercise; (2) nine men and eight women pre- and 3 h post-acute high-intensity interval cycling exercise (HIIE); and (3) eleven men and eight women pre- and post- a 6-week period of high-intensity interval training (HIIT) or nonexercise control. We used RT-PCR and Western blotting to determine the mRNA and protein levels, respectively. Immunolabelling, microscopy, and subcellular fractionation were also performed to assess PERM1 cellular localization. Fasting did not induce detectable changes in the PERM1-related pathways. HIIE significantly increased p-p38MAPK ( p < 0.05, d = 1.27) protein, and PERM1 ( p < 0.05, d = 0.781) and PGC-1α ( p < 0.05, d = 1.51) mRNA. Six weeks of HIIT increased the protein levels of PERM1 isoform 2 ( p < 0.05, ƞ 2  = 0.168) and CKMT2 ( p < 0.05, ƞ 2  = 0.226). PERM1 was localized in the perinuclear region and enriched in the mitochondria. Our results suggest that only some components of PERM1-related pathways are preserved in human skeletal muscle, highlighting the importance of future studies examining PERM1 function in humans.

30 August 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
ACAlessandra Chiarot
Alessandra Chiarot
MMMahek Minhas
Mahek Minhas
NMNicoletta M de Maat
Nicoletta M de Maat
JDJenny Doan
Jenny Doan
Mats NilssonMats Nilsson
Mats Nilsson
mark tarnopolskymark tarnopolsky
mark tarnopolsky
Ovarian aging is characterized by mitochondrial dysfunction, oxidative stress, and inflammation. The development of adjunctive treatments that mitigate age-related subfertility is warranted. We examined the benefits of nutraceutical supplementation (FE; Fertility Enhancer) with mitochondrial antioxidants, anti-inflammatory agents, metabolic activators, vitamins and minerals, and amino acids on ovarian aging, metabolic activity, and reproductive success in young (Y; 6-month-old) and middle-aged (O; 11-month-old) female C57BL/6J mice. The mice were fed calorie- and macronutrient-matched diets w/wo the FE supplement for three months and harem mated twice. Daily FE supplementation promoted significant body re-composition, including loss of white adipose tissue (gWAT: −36% vs. CON, p < 0.001), gain of skeletal muscle (SkM: +67% vs. CON, p < 0.001), and improved SkM/gWAT ratio (+185% vs. CON, p < 0.001). Metabolic testing showed enhanced fat oxidation (+38%, p < 0.01) and energy expenditure (+7%, p = 0.051) in FE mice. Breeding and immunoblotting data demonstrated improved reproductive success (Y-CON: 44%, Y-FE: 89%, O-CON: 0%, O-FE: 18%) and a modest attenuation of ovarian aging markers in both FE groups. We surmise that a multi-ingredient supplement, such as the Fertility Enhancer, may improve body re-composition, metabolic activity, and markers of ovarian aging, thus enhancing reproductive health and fertility in females.